Acknowledgements
The authors wish to thank Dr Adnan Mansoor for advice on the methodology of Ki67 evaluation in Alberta.
Disclosure statement
RP has received honoraria from Beigene and Kite. CO has received honararia from Janssen, AbbVie, AstraZeneca, Beigene, Novartis, and Incyte Biosciences Canada. LS has received honoraria from Seattle Genetics, Kyowa Kirin and Recordati. SP has received honoraria from Beigne, Novartis, Seattle Genetics, and Sobi. AP has received honoraria from AbbVie, AstraZeneca, Janssen, Roche, Incyte, Beigene, Novartis, Seattle Genetics, and Gilead. DS has received honoraria from Abbvie, AstraZeneca, Amgen, Celgene, Gilead, Janssen, Novartis, Roche, Sandoz, and Teva.
Data availability statement
Data may be available from the authors upon reasonable request.